Neil Chatterji
Stock Analyst at B. Riley Securities
(1.42)
# 3,334
Out of 4,868 analysts
17
Total ratings
23.53%
Success rate
0.31%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $15 → $20 | $11.25 | +77.78% | 2 | Jan 28, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $13.09 | -0.69% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $38.03 | +31.48% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $1.23 | +509.76% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $12.33 | +45.99% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $3.25 | +38.46% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $0.70 | +400.57% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.26 | +143.36% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $2.16 | +339.81% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Jan 28, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $11.25
Upside: +77.78%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $13.09
Upside: -0.69%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $38.03
Upside: +31.48%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $1.23
Upside: +509.76%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $12.33
Upside: +45.99%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $3.25
Upside: +38.46%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $0.70
Upside: +400.57%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.26
Upside: +143.36%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $2.16
Upside: +339.81%